Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease


YILMAZ Y., ULUKAYA E., Gul O. O., Arabul M., Gul C. B., ATUĞ Ö., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.42, sa.9, ss.802-807, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 9
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1016/j.clinbiochem.2009.02.003
  • Dergi Adı: CLINICAL BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.802-807
  • Anahtar Kelimeler: Fatty liver, Biological markers, Receptor for advanced glycation endproducts (RAGE), Enzyme-linked immunosorbent assay, END-PRODUCTS AGES, INSULIN-RESISTANCE, SERUM-LEVELS, RAGE, FORM, PATHOGENESIS, GALECTIN-3, PROTEIN
  • Marmara Üniversitesi Adresli: Evet

Özet

Objectives: Levels of soluble receptor for advanced glycation endproducts (sRAGE) have been linked to several components of the metabolic syndrome. We tested the hypothesis that plasma levels of sRAGE may be associated with non-alcoholic fatty liver disease.